Q4 2024 agilon health inc Earnings Call Transcript
Key Points
- Agilon Health Inc (AGL) reported a 44% increase in total revenue for the fourth quarter, reaching $1.52 billion, driven by the expansion of the 2024 partner class and organic growth.
- The company successfully reduced its Medicare Part D exposure to less than 30% of its membership, exceeding its initial goal of 50%, which is expected to reduce risk.
- Agilon Health Inc (AGL) achieved a 36% year-over-year increase in Medicare Advantage membership, reaching 527,000 members by the end of the fourth quarter.
- The company has implemented strategic actions to improve financial performance, including exiting unprofitable partnerships and enhancing data and analytics capabilities.
- Agilon Health Inc (AGL) has a strong pipeline for the class of 2026, with signed letters of intent, indicating continued growth potential.
- The company reported an adjusted EBITDA loss of $84 million for the fourth quarter and $154 million for the full year, reflecting lower medical margins and higher costs.
- Agilon Health Inc (AGL) anticipates a 4% decline in Medicare Advantage membership for 2025, due to partnership exits and payor contract terminations.
- The company is facing ongoing challenges in the Medicare Advantage market, including elevated cost trends and regulatory changes impacting its 2025 outlook.
- Medical margin for the full year 2024 was negatively impacted by prior year development and elevated medical cost trends, resulting in a lower-than-expected outcome.
- Agilon Health Inc (AGL) expects continued high medical cost trends in 2025, with an estimated gross cost trend of 6.3%, posing a challenge to financial performance.
Hello, and welcome to the Agilon fourth-quarter 2024 earnings conference. My name is Elliot, and I'll be coordinating your call today. (Operator Instructions)
I'd now like to hand over to Evan Smith. Please go ahead.
Thank you, operator. Good afternoon and welcome to the call. With me is our CEO, Steve Sell; and our CFO, Jeff Schwaneke. Following our prepared remarks, we will conduct a Q&A session.
Before we begin, I'd like to remind you that our remarks and responses to questions may include forward-looking statements. Actual results may differ materially from those stated or implied by forward-looking statements due to risks and uncertainties associated with our business. These risks and uncertainties are discussed in our SEC filings. Please note that we assume no obligation to update any forward-looking statements.
Additionally, certain financial measures we will discuss in this call are non-GAAP financial measures. We believe that providing these measures helps investors
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
